These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16409673)

  • 1. Multicentric Castleman's disease in HIV infection.
    Collins LS; Fowler A; Tong CY; de Ruiter A
    Int J STD AIDS; 2006 Jan; 17(1):19-24; quiz 25. PubMed ID: 16409673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric Castleman's disease in a patient with HIV.
    Fowler A; Collins L; de Ruiter A; Whittaker S; Kulasegaram R; Bradbeer C
    Int J STD AIDS; 2006 Jan; 17(1):63-4. PubMed ID: 16409683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-associated multicentric Castleman's disease.
    Stebbing J; Pantanowitz L; Dayyani F; Sullivan RJ; Bower M; Dezube BJ
    Am J Hematol; 2008 Jun; 83(6):498-503. PubMed ID: 18260115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castleman's disease and HIV infection in Australia.
    Loi S; Goldstein D; Clezy K; Milliken ST; Hoy J; Chipman M
    HIV Med; 2004 May; 5(3):157-62. PubMed ID: 15139981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
    Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
    AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human herpesvirus 8 DNA in HIV-negative Japanese patients with multicentric Castleman's disease and related diseases.
    Tohda S; Murakami N; Nara N
    Int J Mol Med; 2001 Nov; 8(5):549-51. PubMed ID: 11605026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicentric Castleman's disease treated with combination chemotherapy and rituximab in four HIV-positive men: a case series.
    Bestawros A; Michel R; Séguin C; Routy JP
    Am J Hematol; 2008 Jun; 83(6):508-11. PubMed ID: 18027834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
    Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
    J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term remission in HIV-negative patients with multicentric Castleman's disease using rituximab.
    Ide M; Kawachi Y; Izumi Y; Kasagi K; Ogino T
    Eur J Haematol; 2006 Feb; 76(2):119-23. PubMed ID: 16405432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease.
    Bacon CM; Miller RF; Noursadeghi M; McNamara C; Du MQ; Dogan A
    Br J Haematol; 2004 Dec; 127(5):585-91. PubMed ID: 15566362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's disease.
    Kotb R; Vincent I; Dulioust A; Peretti D; Taburet AM; Delfraissy JF; Goujard C
    Eur J Haematol; 2006 Mar; 76(3):269-71. PubMed ID: 16451402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell response.
    El-Daly H; Bower M; Naresh KN
    Eur J Haematol; 2010 Feb; 84(2):133-6. PubMed ID: 19799625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentric Castleman's disease & HIV infection.
    Cotter A; Lambert J; O'Gorman P
    Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of multicentric Castleman's disease in HIV infection with the rare complication of acquired angioedema.
    Fernando I; Scott G
    Int J STD AIDS; 2014 Jun; 25(7):523-5. PubMed ID: 24352125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.
    Naresh KN; Rice AJ; Bower M
    Am J Surg Pathol; 2008 Jul; 32(7):1006-12. PubMed ID: 18469709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease.
    Bower M; Newsom-Davis T; Naresh K; Merchant S; Lee B; Gazzard B; Stebbing J; Nelson M
    J Clin Oncol; 2011 Jun; 29(18):2481-6. PubMed ID: 21555697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial.
    Gérard L; Bérezné A; Galicier L; Meignin V; Obadia M; De Castro N; Jacomet C; Verdon R; Madelaine-Chambrin I; Boulanger E; Chevret S; Agbalika F; Oksenhendler E
    J Clin Oncol; 2007 Aug; 25(22):3350-6. PubMed ID: 17664482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
    Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
    Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
    van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
    Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
    Lee FC; Merchant SH
    Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.